These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 18271560)

  • 1. Synthesis of a novel macrocyclic library: discovery of an IGF-1R inhibitor.
    Qvit N; Reuveni H; Gazal S; Zundelevich A; Blum G; Niv MY; Feldstein A; Meushar S; Shalev DE; Friedler A; Gilon C
    J Comb Chem; 2008; 10(2):256-66. PubMed ID: 18271560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lead identification to generate isoquinolinedione inhibitors of insulin-like growth factor receptor (IGF-1R) for potential use in cancer treatment.
    Mayer SC; Banker AL; Boschelli F; Di L; Johnson M; Kenny CH; Krishnamurthy G; Kutterer K; Moy F; Petusky S; Ravi M; Tkach D; Tsou HR; Xu W
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3641-5. PubMed ID: 18501599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, antiviral activity, and conformational studies of a P3 aza-peptide analog of a potent macrocyclic tripeptide HCV protease inhibitor.
    Randolph JT; Zhang X; Huang PP; Klein LL; Kurtz KA; Konstantinidis AK; He W; Kati WM; Kempf DJ
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2745-50. PubMed ID: 18375121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and initial SAR of 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-ones as inhibitors of insulin-like growth factor 1-receptor (IGF-1R).
    Velaparthi U; Wittman M; Liu P; Stoffan K; Zimmermann K; Sang X; Carboni J; Li A; Attar R; Gottardis M; Greer A; Chang CY; Jacobsen BL; Sack JS; Sun Y; Langley DR; Balasubramanian B; Vyas D
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2317-21. PubMed ID: 17317169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lead identification to generate 3-cyanoquinoline inhibitors of insulin-like growth factor receptor (IGF-1R) for potential use in cancer treatment.
    Miller LM; Mayer SC; Berger DM; Boschelli DH; Boschelli F; Di L; Du X; Dutia M; Floyd MB; Johnson M; Kenny CH; Krishnamurthy G; Moy F; Petusky S; Tkach D; Torres N; Wu B; Xu W
    Bioorg Med Chem Lett; 2009 Jan; 19(1):62-6. PubMed ID: 19041240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parallel synthesis of diarylureas and their evaluation as inhibitors of insulin-like growth factor receptor.
    Anderson MO; Yu H; Penaranda C; Maddux BA; Goldfine ID; Youngren JF; Guy RK
    J Comb Chem; 2006; 8(5):784-90. PubMed ID: 16961415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of steroid-biaryl ether hybrid macrocycles with high skeletal and side chain variability by multiple multicomponent macrocyclization including bifunctional building blocks.
    Wessjohann LA; Rivera DG; Coll F
    J Org Chem; 2006 Sep; 71(20):7521-6. PubMed ID: 16995654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoenzymatic synthesis of a new class of macrocyclic oligosaccharides.
    Muthana S; Yu H; Cao H; Cheng J; Chen X
    J Org Chem; 2009 Apr; 74(8):2928-36. PubMed ID: 19296596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A biomimetic approach for polyfunctional secocholanes: tuning flexibility and functionality on peptidic and macrocyclic scaffolds derived from bile acids.
    Rivera DG; Pando O; Bosch R; Wessjohann LA
    J Org Chem; 2008 Aug; 73(16):6229-38. PubMed ID: 18642868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of new linear guanidines and macrocyclic amidinourea derivatives endowed with high antifungal activity against Candida spp. and Aspergillus spp.
    Manetti F; Castagnolo D; Raffi F; Zizzari AT; Rajamäki S; D'Arezzo S; Visca P; Cona A; Fracasso ME; Doria D; Posteraro B; Sanguinetti M; Fadda G; Botta M
    J Med Chem; 2009 Dec; 52(23):7376-9. PubMed ID: 19650630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and biological evaluation of a macrocyclic discodermolide/dictyostatin hybrid.
    Paterson I; Gardner NM
    Chem Commun (Camb); 2007 Jan; (1):49-51. PubMed ID: 17279257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linear presentation of variable side-chain spacing in a highly diverse combinatorial library.
    Krchnák V; Weichsel AS; Cabel D; Lebl M
    Pept Res; 1995; 8(4):198-205. PubMed ID: 8527873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New macrocyclic compound as chiral shift reagent for carboxylic acids.
    Ma F; Ai L; Shen X; Zhang C
    Org Lett; 2007 Jan; 9(1):125-7. PubMed ID: 17192101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of an inhibitor of insulin-like growth factor 1 receptor activation: implications for cellular potency and selectivity over insulin receptor.
    Wood ER; Shewchuk L; Hassel A; Nichols J; Truesdale AT; Smith D; Carter HL; Weaver K; Barrett G; Leesnitzer T; Alvarez E; Bardera AI; Alamillo A; Cantizani J; Martin J; Smith GK; Jensen DE; Xie H; Mook R; Kumar R; Kuntz K
    Biochem Pharmacol; 2009 Dec; 78(12):1438-47. PubMed ID: 19665448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor-1 receptor acts as a growth regulator in synovial sarcoma.
    Friedrichs N; Küchler J; Endl E; Koch A; Czerwitzki J; Wurst P; Metzger D; Schulte JH; Holst MI; Heukamp LC; Larsson O; Tanaka S; Kawai A; Wardelmann E; Buettner R; Pietsch T; Hartmann W
    J Pathol; 2008 Dec; 216(4):428-39. PubMed ID: 18855347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient large-scale synthesis of BILN 2061, a potent HCV protease inhibitor, by a convergent approach based on ring-closing metathesis.
    Yee NK; Farina V; Houpis IN; Haddad N; Frutos RP; Gallou F; Wang XJ; Wei X; Simpson RD; Feng X; Fuchs V; Xu Y; Tan J; Zhang L; Xu J; Smith-Keenan LL; Vitous J; Ridges MD; Spinelli EM; Johnson M; Donsbach K; Nicola T; Brenner M; Winter E; Kreye P; Samstag W
    J Org Chem; 2006 Sep; 71(19):7133-45. PubMed ID: 16958506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid generation of macrocycles with natural-product-like side chains by multiple multicomponent macrocyclizations (MiBs).
    Rivera DG; Vercillo OE; Wessjohann LA
    Org Biomol Chem; 2008 May; 6(10):1787-95. PubMed ID: 18452014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of new small molecules that influence neuroblast cell migration from the subventricular zone.
    Rolland A; Boquet I; Norreel JC; Moret V; Laras Y; Kraus JL
    Bioorg Med Chem Lett; 2008 Jan; 18(1):169-74. PubMed ID: 18024032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chiral tetraazamacrocycles having four pendant-arms.
    Kamioka S; Takahashi T; Kawauchi S; Adachi H; Mori Y; Fujii K; Uekusa H; Doi T
    Org Lett; 2009 Jun; 11(11):2289-92. PubMed ID: 19432409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro selection of multiple libraries created by genetic code reprogramming to discover macrocyclic peptides that antagonize VEGFR2 activity in living cells.
    Kawakami T; Ishizawa T; Fujino T; Reid PC; Suga H; Murakami H
    ACS Chem Biol; 2013; 8(6):1205-14. PubMed ID: 23517428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.